Aidoc
Aidoc provides AI-powered services for the healthcare industry, offering solutions for medical imaging analysis via its proprietary aiOS™ platform.
Secondary Market Price
How Aidoc Measures Up
To help you manage your Aidoc equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series D
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Aidoc's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Aidoc Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Aidoc's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Aidoc is a healthcare technology company that provides artificial intelligence services for medical professionals. The company's main offering is an operating system, aiOS™, which analyzes and aggregates medical data to assist care teams. Its AI solutions are applied in various fields, including radiology, cardiology, and neurology, with specific applications for echocardiography, neurotrauma, and spine imaging. Founded in 2016 by Elad Walach, Gal Yaniv, and Guy Reiner, Aidoc is headquartered in Tel Aviv-Yafo, Israel, with an additional office in New York.
Recently, Aidoc received FDA clearance for its foundation model AI, CARE™, which unifies 14 acute indications into a single workflow for emergency departments and imaging backlogs. The company plans to expand this platform across all CT and X-ray workflows over the next 18 months, with a goal of enabling automated draft report creation. Aidoc has implemented its aiOS™ platform at health systems such as Sutter Health and Temple University Health System to support clinical workflows. The company also continues to present its research, with new abstracts on its stroke solution scheduled for the International Stroke Conference 2026.
- General Catalyst
- Square Peg Capital
- NVentures
- Hartford HealthCare
- Mercy
- Sutter Health
- WellSpan Health
- TCV
- Alpha Intelligence Capital
- CDIB Capital
- TLV Partners
- Maor Investments
- Magma Venture Partners
- Emerge
- Co-Founder, Elad Walach
- Co-Founder, Michael Braginsky
- Co-Founder, Guy Reiner
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Aidoc worth joining?
Deciding whether to join Aidoc depends on your personal career goals and how you evaluate the potential of their equity compensation package. Tools like Prospect can help you model the potential value of your stock options to make a more informed decision.
What should I do with my Aidoc stock?
Managing your Aidoc stock requires a personalized strategy based on your financial goals, tax situation, and the company's performance. Platforms like Prospect offer tools to help you understand tax implications and decide on the best time to exercise your options or sell your shares.
Can you sell Aidoc stock?
As Aidoc is a private company, selling stock is typically restricted and can only be done through secondary markets or company-organized tender offers. You can use a platform like Prospect to monitor for liquidity events and understand how to maximize your take-home pay when an opportunity to sell arises.
How can I find the value of my Aidoc stock?
For a private company like Aidoc, the stock value is typically determined by its latest 409A valuation, which is not public information but should be available to employees. To better understand the potential future value, you can use equity management platforms like Prospect which model various outcomes for your equity.
What is Aidoc's equity worth?
The total equity worth, or valuation, of a private company like Aidoc is established during its funding rounds and is not publicly disclosed. Your personal equity's value depends on your grant size and the company's current valuation, which platforms like Prospect can help you track and project.
What is Aidoc's stock ticker symbol?
Aidoc does not have a stock ticker symbol because it is a private company and its shares are not traded on a public stock exchange. Ticker symbols are only assigned to companies once they complete an Initial Public Offering (IPO).
Can I buy or sell Aidoc stock?
As a private company, buying Aidoc stock is usually reserved for accredited investors during funding rounds, while selling is restricted to specific events like tender offers. Tools like Prospect can help you prepare for and navigate these limited opportunities to sell your shares.
What is the criteria to buy or invest in Aidoc stock?
Investing in a private company like Aidoc is typically restricted to accredited investors who participate in organized funding rounds. Employees receive equity as compensation and can use tools like Prospect to manage their grants and understand the terms.
